What does business segments — provision for income taxes mean?

This metric represents the estimated income tax expense recognized by the business segment based on its taxable earnings for the reporting period. It accounts for both current tax liabilities and deferred tax impacts resulting from temporary differences between financial reporting and tax regulations. Understanding this provision is critical for assessing the segment's effective tax rate and its impact on net profitability.

Tarsus Pharmaceuticals, Inc. TARS Business Segments — Provision for income taxes

Similar metrics at other companies

PATHReportable Segment — Provision for income taxes

$18.44M+552%

MSMReportable Segment — Provision for income taxes

$13.86M+10.3%

RNGReportable Segment — Provision for income taxes

$3.49M-41.4%

ARQTReportable Segment — Provision for income taxes

$93K-66.7%

LCIDReportable Segment — Provision for (benefit from) income taxes

$177K+113%

OMCLReportable Segment — Provision for (benefit from) income taxes

$5.55M+321%

Other financials

Income statement

See full

Revenue$162.1M+107%

Gross profit$152.7M+109%

Operating income-$6.1M+76.7%

Net income-$7.0M+72.3%

EPS (diluted)-$0.16+75.0%

Balance sheet

See full

Cash & equivalents$104.2M-41.6%

Total debt$88.7M+22.5%

Total equity$349.0M+1.9%

Total assets$581.1M+16.1%

Cash flow

See full

Operating cash flow-$24.7M-19.4%

CapEx$5.8M+886%

Free cash flow-$30.5M-43.4%

Valuation

See full

Market cap$2.85B+41.1%

Enterprise value$2.83B+47.8%

P/S5.3×-3.3×

Profitability

See full

Gross margin42.7%—

Operating margin-9.5%-4.2pp

Net margin-9%-4.0pp

FCF margin-28%-12.6pp

Returns & leverage

See full

Return on equity-14%-5.2pp

Debt / equity0.3×0.0×

Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s business segments — provision for income taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s business segments — provision for income taxes?: Tarsus Pharmaceuticals, Inc. (TARS) reported business segments — provision for income taxes of -$2.35M in Q1 2026.
What does business segments — provision for income taxes mean?: This metric represents the estimated income tax expense recognized by the business segment based on its taxable earnings for the reporting period. It accounts for both current tax liabilities and deferred tax impacts resulting from temporary differences between financial reporting and tax regulations. Understanding this provision is critical for assessing the segment's effective tax rate and its impact on net profitability.